Table 5.
Model parameter | Baseline |
Magnitude effect |
||
---|---|---|---|---|
Mdiff | dBF | Mdiff | dBF | |
Log(k) | 2.26 | 77.9 | −0.093 | 0.47 |
Drift rate coefficient | −0.365 | 0.061 | 0.020 | 2.73 |
Nondecision time | 0.180 | 98.4 | −0.0001 | 0.95 |
Boundary separation | −0.047 | 0.60 | 0.017 | 1.47 |
Starting point bias | −0.004 | 0.74 | −0.017 | 0.26 |
Drift rate maximum | 0.18 | 8.27 | 0.16 | 16.88 |
aFor each parameter, we report mean posterior group differences (Mdiff) and BFs (dBF) testing for directional effects on both the baseline parameter in the 100€ condition (left columns) and on the magnitude effect on each parameter (right columns). BFs < 0.33 reflect evidence for placebo < haloperidol, whereas BFs >3 reflect evidence for placebo > haloperidol. For details, see Statistical analyses.